tradingkey.logo

DSS Inc

DSS

0.832USD

-0.013-1.57%
Fechamento 08/14, 16:00ETCotações atrasadas em 15 min
7.56MValor de mercado
PerdaP/L TTM
Mais detalhes de DSS Inc Empresa
DSS, Inc. is a multinational, public company. It operates its business through six divisions: Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, Alternative Trading, and Direct Marketing. The Product Packaging division operates through Premier Packaging Corporation, Inc., which markets, manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through its operating company, American Pacific Bancorp, Inc., which represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena. Digital Transformation serves as a Preferred Technology Partner and Application Development Solution for mid-cap brands across various industries.
Informações da empresa
Código da empresaDSS
Nome da EmpresaDSS Inc
Data de listagemOct 27, 1993
CEOMr. Jason Grady
Número de funcionários100
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 27
Endereço275 Wiregrass Pkwy
CidadeWEST HENRIETTA
Bolsa de valoresNYSE American Consolidated
PaísUnited States of America
Código postal14586
Telefone15852321500
Sitehttps://www.dssworld.com/
Código da empresaDSS
Data de listagemOct 27, 1993
CEOMr. Jason Grady
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Jason Grady
Mr. Jason Grady
Interim Chief Executive Officer
Interim Chief Executive Officer
125.00
--
Mr. Jose Escudero
Mr. Jose Escudero
Independent Director
Independent Director
51.00
--
Ms. Hiu Pan (Joanne) Wong
Ms. Hiu Pan (Joanne) Wong
Independent Director
Independent Director
--
--
Mr. Sheng Hon (Danny) Lim
Mr. Sheng Hon (Danny) Lim
Director
Director
--
--
Mr. Heng Fai (Ambrose) Chan
Mr. Heng Fai (Ambrose) Chan
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Wai Leung (William) Wu
Mr. Wai Leung (William) Wu
Lead Independent Director
Lead Independent Director
--
--
Mr. Todd D. Macko
Mr. Todd D. Macko
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Tung Moe Chan
Mr. Tung Moe Chan
Director
Director
--
--
Mr. Shui Yeung (Frankie) Wong, CPA
Mr. Shui Yeung (Frankie) Wong, CPA
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Jason Grady
Mr. Jason Grady
Interim Chief Executive Officer
Interim Chief Executive Officer
125.00
--
Mr. Jose Escudero
Mr. Jose Escudero
Independent Director
Independent Director
51.00
--
Ms. Hiu Pan (Joanne) Wong
Ms. Hiu Pan (Joanne) Wong
Independent Director
Independent Director
--
--
Mr. Sheng Hon (Danny) Lim
Mr. Sheng Hon (Danny) Lim
Director
Director
--
--
Mr. Heng Fai (Ambrose) Chan
Mr. Heng Fai (Ambrose) Chan
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Wai Leung (William) Wu
Mr. Wai Leung (William) Wu
Lead Independent Director
Lead Independent Director
--
--
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2023
FY2023Q1
FY2022
FY2022Q1
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Packaging Printing and Fabrication
3.86M
77.98%
Commercial and Security Printing
135.00K
2.73%
Sem dados
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Packaging Printing and Fabrication
3.86M
77.98%
Commercial and Security Printing
135.00K
2.73%
Distribuição de ações
Atualizado em: há 7 horas
Atualizado em: há 7 horas
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Alset Ehome International Inc
40.14%
Chan (Heng Fai Ambrose)
13.06%
Global Biomedical Pte Ltd.
3.43%
Heuszel (Frank D.)
0.72%
Citadel Advisors LLC
0.48%
Outro
42.17%
Investidores
Investidores
Proporção
Alset Ehome International Inc
40.14%
Chan (Heng Fai Ambrose)
13.06%
Global Biomedical Pte Ltd.
3.43%
Heuszel (Frank D.)
0.72%
Citadel Advisors LLC
0.48%
Outro
42.17%
Tipos de investidores
Investidores
Proporção
Corporation
43.57%
Individual Investor
13.78%
Hedge Fund
0.98%
Investment Advisor
0.61%
Investment Advisor/Hedge Fund
0.21%
Outro
40.84%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
41
5.38M
59.16%
+1.09K
2025Q1
42
5.38M
59.16%
+7.88K
2024Q4
44
5.34M
75.51%
+934.13K
2024Q3
50
4.36M
61.72%
-49.38K
2024Q2
55
4.37M
61.87%
-23.78K
2024Q1
58
4.35M
61.59%
-43.12K
2023Q4
57
4.38M
62.50%
-18.04K
2023Q3
61
4.33M
61.80%
-325.98K
2023Q2
66
4.33M
62.32%
-279.86K
2023Q1
73
4.27M
61.44%
-358.54K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Alset Ehome International Inc
3.65M
40.14%
--
--
Feb 26, 2025
Chan (Heng Fai Ambrose)
1.19M
13.06%
--
--
Feb 26, 2025
Global Biomedical Pte Ltd.
311.63K
3.43%
--
--
Feb 26, 2025
Heuszel (Frank D.)
65.64K
0.72%
--
--
Feb 26, 2025
Citadel Advisors LLC
58.33K
0.64%
+58.33K
--
Mar 31, 2025
Renaissance Technologies LLC
26.25K
0.29%
+1.00K
+3.96%
Mar 31, 2025
The Vanguard Group, Inc.
21.73K
0.24%
-21.59K
-49.84%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
20.98K
0.23%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
19.67K
0.22%
+7.16K
+57.24%
Mar 31, 2025
Ferguson Wellman Capital Management, Inc.
12.75K
0.14%
--
--
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: qua, 6 de ago
Atualizado em: qua, 6 de ago
Nome
Proporção
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
Proporção0%
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Nov 08, 2023
Merger
20<1
Nov 08, 2023
Merger
20<1
Nov 08, 2023
Merger
20<1
Nov 08, 2023
Merger
20<1
May 05, 2020
Merger
30<1
May 05, 2020
Merger
30<1
Data
Tipo
Proporção
Nov 08, 2023
Merger
20<1
Nov 08, 2023
Merger
20<1
Nov 08, 2023
Merger
20<1
Nov 08, 2023
Merger
20<1
May 05, 2020
Merger
30<1
May 05, 2020
Merger
30<1
May 05, 2020
Merger
30<1
May 05, 2020
Merger
30<1
KeyAI